Shares of Revolution Medicines (RVMD) are up $23.05, or 29%, to $102.90 after The Wall Street Journal reported that AbbVie (ABBV) is in advanced talks to buy the cancer-drug maker.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD: